Taimei Technology (HK.02576) and C&R Research (A359090) signed an enterprise-level strategic partnership to develop an AI‑based clinical trial operations system.
The collaboration will deploy Taimei’s digital infrastructure and AI Agents, including EDC + iDM, to automate trial design, data capture, and governance.
AI‑driven tools like eCRF generation, automated test cases, and intelligent data management aim to boost productivity and quality in Korean CRO trials.
CEOs Moon Tae Yoon and Zhao Lu said AI is a competitive factor and will accelerate South Korea’s clinical trial digital transformation.